Zhecheva I. Enhancing the treatment effectivity of patients with neovascularized leucomas by means of use of immunosuppressants of various mechanism of action - Dexamethasone and CellCept after penetrating keratoplasty.

Українська версія

Thesis for the degree of Candidate of Sciences (CSc)

State registration number

0402U002540

Applicant for

Specialization

  • 14.01.18 - Очні хвороби

05-07-2002

Specialized Academic Board

Д 41.556.01

State Institution "The Filatov Institute of Eye Disease and Tissue Therapy of NAMS of Ukraine"

Essay

3.The patients with neovascularized leucomas. To increase the efficacy of treatment of patients with neovascularized leucomas by preventing immunological corneal graft rejection after penetrating high-risk keratoplasty by means of use of immunosuppressants Dexamethasone or CellCept. In patients at high-risk of allograft rejection CellCept systemic monotherapy given with the purpose of prevention significantly reduces the incidence of acute rejection: overall rejection- free graft survival was 62,7% and overall graft survival was 81,8%. The improved immunosuppressive treatment method was introduced in Keratoplasty department practice in The Filatov Institute. The sphere of application is medicine, ophthalmology.

Files

Similar theses